Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,495 | 55,303 | 62,977 | 44,049 | 46,971 |
| Marketable Securities | 4,534 | N/A | 3,413 | 21,575 | 41,987 |
| Receivables | 947 | 2,341 | 1,854 | 16,135 | 14,575 |
| TOTAL | $44,416 | $59,128 | $71,503 | $85,424 | $105,577 |
| Non-Current Assets | |||||
| PPE Net | 5,372 | 11,295 | 14,685 | 15,863 | 19,011 |
| Other Non-Current Assets | 213 | 239 | 45 | 2,960 | 3,217 |
| TOTAL | $5,585 | $11,534 | $14,730 | $18,823 | $22,228 |
| Total Assets | $50,001 | $70,662 | $86,233 | $104,247 | $127,805 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,619 | 3,245 | 1,654 | 3,500 | 4,031 |
| Accrued Expenses | 8,228 | 14,282 | 14,900 | 16,193 | 12,351 |
| Other current liabilities | N/A | N/A | 0 | N/A | 1,238 |
| TOTAL | $26,555 | $40,355 | $38,881 | $32,997 | $32,644 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,139 | 8,930 | 12,491 | 3,088 | 6,001 |
| Deferred Revenues | 5,830 | 11,106 | 14,373 | 2,208 | 4,294 |
| Other Non-Current Liabilities | 713 | 540 | 540 | 7,646 | 3,492 |
| TOTAL | $8,852 | $9,701 | $13,082 | $24,292 | $30,895 |
| Total Liabilities | $35,407 | $50,056 | $51,963 | $57,289 | $63,539 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,507 | 5,214 | 5,226 | 5,230 | 5,227 |
| Common Shares | 55 | 52 | 52 | 52 | 52 |
| Retained earnings | -490,902 | -480,028 | -466,134 | -451,698 | -433,739 |
| Other shareholders' equity | 0 | 0 | 0 | 2 | 7 |
| TOTAL | $14,594 | $20,606 | $34,270 | $46,958 | $64,266 |
| Total Liabilities And Equity | $50,001 | $70,662 | $86,233 | $104,247 | $127,805 |